Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Funding Sources for Scientific Discovery, Medical Research

Simon M. Helfgott, MD  |  Issue: March 2017  |  March 20, 2017

Another disruptive form of philanthropy is called mission investing, in which philanthropies act more like business partners and expect a share of profits stemming from any discoveries made with the help of their support. A prime example is the partnership between the Cystic Fibrosis Foundation (CFF) and Vertex Pharmaceuticals of Boston, which was given $150 million by the CFF to develop new therapies for this incurable disease. One drug, ivacaftor, has been developed and the CFF recently sold its rights to its royalty stream to an investment firm for $3.3 billion, yielding a 20-times return on investment.15

Ice Buckets

Dumping ice water was best known as a prank carried out by jubilant athletes who would hurl buckets containing a slurry of Gatorade and ice chips onto their coaches’ heads just moments before winning a championship game. Then a few years ago, a patient with amyotrophic lateral sclerosis (ALS), Pat Quinn, thought it may be fun to try this mischief on his friend, Pete Frates a former captain of the Boston College baseball team who was diagnosed with ALS at age 27. Savvy social media use catapulted the Ice Bucket Challenge into the coolest, and among the most effective, fundraising efforts in years, raising an astounding $115 million.16

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

When you can’t find a supportive billionaire to fund your enterprise, try thinking of a great idea—preferably one that is so simple, yet so brilliant.


Simon M. Helfgott, MDSimon M. Helfgott, MD, is associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School in Boston.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. McCarthy E. Bob Dylan acknowledges Nobel Prize. The Washington Post. 2016 Oct 29.
  2. Whipple T. Nobel calling. The Economist 1843 Magazine. September/October 2013.
  3. Schuessler J. MacArthur Foundation announces 2016 ‘genius’ grant winners. The New York Times. 2016 Sep 22.
  4. Vierger RF, Hendriks TC. The 10 largest public and philanthropic funders of health research in the world: What they fund and how they distribute their fund. Health Res Policy Syst. 2016 Feb 18;14:12.
  5. Nobel laureates. The NIH Almanac. 2016 Oct 11.
  6. NIH research funding trends. Federation of American Societies for Experimental Biology.
  7. Blendon RJ. The changing role of private philanthropy in health affairs. N Engl J Med. 1975 May 1;292(18):946–950.
  8. History. Howard Hughes Medical Institute. http://www.hhmi.org/about/history.
  9. Bartlett DL, Steele JB. Howard Hughes: His Life and Madness. WW Norton and Co. New York 1979.
  10. Wheeler JL, Rum SA, Wright SM. Philanthropy, medical research, and the role of development. Am J Med. 2014 Oct;127(10):903–904.
  11. Ohman EM, Douglas PS, Dean LB, et al. Philanthropy for science: Is it a viable option? Circ Res. 2016 Oct 28;119(10):1057–1059.
  12. Anft M. When scientific research can’t get federal funds, private money steps in. The Chronicle of Philanthropy. 2015 Feb 8. https://www.philanthropy.com/article/When-Scientific-Research/151777.
  13. Reilly PJ. What is with this Chan Zuckerberg LLC thing? Tax geeks speak. Forbes. 2015 Dec 4.
  14. Lorenzetti L. Sean Parker is funding the first human trials of a revolutionary cancer treatment. Fortune. 2016 Jun 21.
  15. Risser D, Gilblom K. Cystic fibrosis foundation sells drug royalties for $3B. Bloomberg. 2014 Nov 19.
  16. Rogers K. The ‘ice bucket challenge’ helped scientists discover a new gene tied to A.L.S. The New York Times. 2016 Jul 27.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:discoveryfinancialFundinginvestmentmedicalNational Institutes of HealthPhilanthropyResearchrheumatologysupport

Related Articles

    The Non-Linear Path of Discovery, & Publicly Funded Research

    November 19, 2018

    Black powder was initially developed in 9th century China, by Taoists searching for the philosopher’s stone, which fans of Harry Potter will remember is the talisman that grants eternal life. The Chinese name for black powder literally translates as fire medicine. The chemical composition of black powder was first recorded in China during the 11th…

    Funding Crisis Threatens Research and Training in Rheumatology

    October 1, 2014

    The ACR and Rheumatology Research Foundation present data to reinforce importance of supporting rheumatology research

    The ACR, Rheumatology Research Foundation Address Research Funding Shortfall

    July 14, 2015

    I have spent my entire academic career as a clinical investigator and have grown to recognize the importance of a strong and vibrant rheumatology workforce. However, I am deeply concerned about our ability as a subspecialty to sustain our research enterprise and take advantage of the modern breakthroughs in science. The reduction in federal funding…

    Tear Down That Wall: CME restrictions stifle speeches

    August 1, 2010

    The Nobel Peace Prize is one of the most prestigious awards in the world because it recognizes individuals and organizations that promote the causes of peace and human rights. In 1991, Aung San Suu Kyi received this prize for her courageous work in advancing democracy in the Republic of Myanmar. Because of her leadership of the democracy movement in Myanmar, the military regime that governs that country has gone to great lengths to gag her. Indeed, she has been under house arrest for most of the last two decades since she received the Peace Prize. An outpouring of support for Aung San Suu Kyi and demands for her freedom by human rights advocates and Western governments have sadly been to no avail.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences